Paper9704930
Characterization of p53 oligomerization domain mutations isolated from Li-Fraumeni and Li-Fraumeni like family members.
Lomax ME and 4 others. Oncogene, 1998. Cited by 92 papers, by iCite.
Cite this record
ConductScience Library. Characterization of p53 oligomerization domain mutations isolated from Li-Fraumeni and Li-Fraumeni like family members. Papers, record 9704930. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/9704930
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Characterization of p53 oligomerization domain mutations isolated from Li-Fraumeni and Li-Fraumeni like family members.
- PubMed
Topics17
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Arginine | Major topic |
| Cysteine | Major topic |
| Leucine | Major topic |
| Li-Fraumeni Syndrome | Major topic |
| Mutagenesis, Site-Directed | Major topic |
| Nuclear Proteins | Major topic |
| Proline | Major topic |
| Tumor Suppressor Protein p53 | Major topic |
| Apoptosis | |
| Cell Division | |
| DNA Probes | |
| Humans | |
| Neoplasm Proteins | |
| Proto-Oncogene Proteins | |
| Proto-Oncogene Proteins c-mdm2 | |
| Transcriptional Activation | |
| Tumor Cells, Cultured |
Source PubMed
Cited by54
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 92 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42080089 | On the potential origin of the zygote-like cancer stem cell with a focus on fusion for cell rescue. | Front Cell Dev Biol | 2026 | https://conductscience.org/library/papers/42080089 | PubMed |
| 40830167 | In-frame germline TP53 variant impairs p53 oligomerization and predisposes to cancer. | Sci Rep | 2025 | https://conductscience.org/library/papers/40830167 | PubMed |
| 40459096 | TP53-Mutated Acute Myeloid Leukemia: Unanswered Questions. | Hematol Oncol | 2025 | https://conductscience.org/library/papers/40459096 | PubMed |
| 40334261 | Correlation of p53 oligomeric status and its subcellular localization in the presence of the AML-associated NPM mutant. | PLoS One | 2025 | https://conductscience.org/library/papers/40334261 | PubMed |
| 38068290 | The Advantages of Next-Generation Sequencing Molecular Classification in Endometrial Cancer Diagnosis. | J Clin Med | 2023 | https://conductscience.org/library/papers/38068290 | PubMed |
| 34881245 | Oligomerization of Mutant p53 R273H is not Required for Gain-of-Function Chromatin Associated Activities. | Front Cell Dev Biol | 2021 | https://conductscience.org/library/papers/34881245 | PubMed |
| 34639121 | TP53 in Acute Myeloid Leukemia: Molecular Aspects and Patterns of Mutation. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/34639121 | PubMed |
| 34386269 | Gallic Acid Induces S and G2 Phase Arrest and Apoptosis in Human Ovarian Cancer Cells In Vitro. | Appl Sci (Basel) | 2021 | https://conductscience.org/library/papers/34386269 | PubMed |
| 34136083 | Frame-shift mediated reduction of gain-of-function p53 R273H and deletion of the R273H C-terminus in breast cancer cells result in replication-stress sensitivity. | Oncotarget | 2021 | https://conductscience.org/library/papers/34136083 | PubMed |
| 33823140 | p53 mediates target gene association with nuclear speckles for amplified RNA expression. | Mol Cell | 2021 | https://conductscience.org/library/papers/33823140 | PubMed |
| 32873579 | p53 tetramerization: at the center of the dominant-negative effect of mutant p53. | Genes Dev | 2020 | https://conductscience.org/library/papers/32873579 | PubMed |
| 31665549 | Regulation of the MDM2-p53 pathway by the ubiquitin ligase HERC2. | Mol Oncol | 2020 | https://conductscience.org/library/papers/31665549 | PubMed |
| 31452792 | Mutations in exon 8 of TP53 are associated with shorter survival in patients with advanced lung cancer. | Oncol Lett | 2019 | https://conductscience.org/library/papers/31452792 | PubMed |
| 30060809 | Ceramide Signaling and p53 Pathways. | Adv Cancer Res | 2018 | https://conductscience.org/library/papers/30060809 | PubMed |
| 29983877 | Mutations of p53 decrease sensitivity to the anthracycline treatments in bladder cancer cells. | Oncotarget | 2018 | https://conductscience.org/library/papers/29983877 | PubMed |
| 29721371 | Complimentary mechanisms of dual checkpoint blockade expand unique T-cell repertoires and activate adaptive anti-tumor immunity in triple-negative breast tumors. | Oncoimmunology | 2018 | https://conductscience.org/library/papers/29721371 | PubMed |
| 29434345 | Cotranslational protein assembly imposes evolutionary constraints on homomeric proteins. | Nat Struct Mol Biol | 2018 | https://conductscience.org/library/papers/29434345 | PubMed |
| 28977907 | NEURL4 regulates the transcriptional activity of tumor suppressor protein p53 by modulating its oligomerization. | Oncotarget | 2017 | https://conductscience.org/library/papers/28977907 | PubMed |
| 28948977 | Therapeutic targeting of p53: all mutants are equal, but some mutants are more equal than others. | Nat Rev Clin Oncol | 2018 | https://conductscience.org/library/papers/28948977 | PubMed |
| 27754743 | p53 oligomerization status modulates cell fate decisions between growth, arrest and apoptosis. | Cell Cycle | 2016 | https://conductscience.org/library/papers/27754743 | PubMed |
Genes3
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| BAX | 581 | PubTator's text mining | https://conductscience.org/library/genes/581 | NCBI Gene |
| MDM2 | 4193 | PubTator's text mining | https://conductscience.org/library/genes/4193 | NCBI Gene |
| TP53 | 7157 | PubTator's text mining | https://conductscience.org/library/genes/7157 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/9704930
GET https://conductscience.org/api/papers/v1/9704930/cited_by?page=2